The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 21,001–21,100 of 31,469
Giraudi, P. J., Gambaro, S. E., Arroyo, S. O., et al. (2017) · Liver International · doi:10.1111/liv.13505 · Cited by 10
Study, C. C., Morgan, B. W., Leifheit, K. M., et al. (2017) · Tobacco Induced Diseases · doi:10.1186/s12971-017-0137-8 · Cited by 10
Lee, W., Kim, J. H., Park, S. E., Park, C. ‐., Oh, K.-W., Park, S.-W., Rhee, E., & Lee, W. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.06.005 · Cited by 9
Sathyapalan, T., Coady, A., Kilpatrick, E. S., & Atkin, S. L. (2017) · Endocrine Connections · doi:10.1530/ec-17-0217 · Cited by 10
The effects of HIV and smoking on aortic and splenic inflammation
Longenecker, C. T., Sullivan, C., Morrison, J. T., et al. (2017) · AIDS · doi:10.1097/qad.0000000000001682 · Cited by 10
de Luis, D. A., Izaola, O., Primo, D., Ovalle, H. F., Gómez, J. J. L., Hoyos, E. G., Ortolá, A., & Aller, R. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000484446 · Cited by 10
Abdominal obesity adversely affects bone mass in children
Krishnan, S., Anderson, M. P., Fields, D. A., & Misra, M. (2018) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v7.i1.43 · Cited by 10
Piché, M., Laberge, A., Brassard, P., Arsenault, B. J., Bertrand, O. F., Després, J., Costerousse, O., & Poirier, P. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13293 · Cited by 10
Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
Glintborg, D., Altinok, M. L., Ravn, P., Stage, K. B., Højlund, K., & Andersen, M. (2018) · Endocrine Connections · doi:10.1530/ec-18-0077 · Cited by 10
Guarnotta, V., Pizzolanti, G., Ciresi, A., & Giordano, C. S. D. S. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0839-7 · Cited by 10
Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study
Balakrishnan, P., Navas‐Acién, A., Haack, K., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.03.034 · Cited by 10
Lontchi‐Yimagou, E., LeGoff, J., Nguewa, J. L., Boudou, P., Balti, E. V., Noubiap, J. J., Kamwa, V., Atogho‐Tiedeu, B., Azabji‐Kenfack, M., Djahmeni, E. N., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12777 · Cited by 10
Quintana‐Castro, R., Rodríguez, I. S., Lago, R. A. D., Pagola, P. G., Rodríguez‐Antolín, J., Quintal, A. P., Rivera, J. R., & Aguilera, A. A. (2018) · Biomedical Papers · doi:10.5507/bp.2018.016 · Cited by 10
Bantle, A., Bosch, T. A., Dengel, D. R., Wang, Q., Mashek, D. G., & Chow, L. S. (2018) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2018.06.001 · Cited by 11
Parthan, G., Bhansali, S., Kurpad, A. V., Walia, R., Bhat, K., & Bhansali, A. (2018) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-018-0228-z · Cited by 10
Relation between plasma Apelin level and peripheral neuropathy in Type 2 diabetic patients
Hosny, S. S., Nasr, M. S., Ibrahim, R. H., et al. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.11.027 · Cited by 10
A Calcium-Deficient Diet in Dams during Gestation Increases Insulin Resistance in Male Offspring
Takaya, J., Yamanouchi, S., Kino, J., Tanabe, Y., & Kaneko, K. (2018) · Nutrients · doi:10.3390/nu10111745 · Cited by 10
Adiponectin levels, lipid profile and glucose metabolism in patients with abdomi-nal obesity
Belyaeva, О. D., Bazhenova, E., Berezina, A. V., et al. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-3-309-313 · Cited by 10
Insulin resistance is associated with hirsutism in unselected reproductive‐aged women
Song, D. K., Lee, H., Hong, Y. S., & Sung, Y. (2019) · Clinical Endocrinology · doi:10.1111/cen.13936 · Cited by 10
Liu, R., Zhao, J., Guo, J., Liu, X., Yu, J., Wang, H., Li, Y., Sun, C., & Liu, L. (2019) · Food & Function · doi:10.1039/c8fo02321b · Cited by 10
Johnston, L., Liu, Z., Retnakaran, R. R., Zinman, B., Giacca, A., Harris, S. B., Bazinet, R. P., & Hanley, A. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p084970 · Cited by 11
Antonopoulou, V., Karras, S. Ν., Koufakis, T., Yavropoulou, M. P., Katsiki, N., Gerou, S., Papavramidis, T. S., & Kotsa, K. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.07.019 · Cited by 10
Insulin resistance associates with hepatic lobular inflammation in subjects with obesity
de Velde, F. V., Bekaert, M., Geerts, A. M., Hoorens, A., Batens, A.-H., Shadid, S., Ouwens, D. M., Nieuwenhove, Y. V., & Lapauw, B. (2019) · Endocrine Connections · doi:10.1530/ec-19-0366 · Cited by 10
Ye, F., Liu, W., Zheng, K. I., Pan, X.-Y., Ma, H., Wang, X., Chen, Y., & Zheng, M. (2019) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001483 · Cited by 10
Ren, G., Bowers, R. L., Kim, T., Araya-Ramírez, F., Mahurin, A. J., Dean, D. M., Grandjean, P. W., & Mathews, S. T. (2020) · Obesity · doi:10.1002/oby.22730 · Cited by 10
Farhangi, M. A. (2020) · BMC Research Notes · doi:10.1186/s13104-020-04993-8 · Cited by 10
Prevalence and risk factors of fatty liver in Portuguese adults
Leitão, J., Carvalhana, S. C., Cochicho, J. G., Silva, A. P., Velasco, F., Medeiros, I., Alves, A. C., Bourbon, M., Oliveiros, B., Rodrigues, V., et al. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13235 · Cited by 10
Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat Diet
Tashiro, Y., Han, Q., TAN, Y., Sugisawa, N., Yamamoto, J., Nishino, H., Inubushi, S., Sun, Y., Zhu, G., LIM, H., et al. (2020) · In Vivo · doi:10.21873/invivo.11865 · Cited by 10
Murai, N., Saito, N., Kodama, E., Iida, T., Mikura, K., Imai, H., Kaji, M., Hashizume, M., Kigawa, Y., Koizumi, G., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa066 · Cited by 10
Mancini, A., Bruno, C., Vergani, E., Guidi, F., Angelini, F., Meucci, E., & Silvestrini, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236357 · Cited by 10
Bullón‐Vela, V., Abete, I., Zulet, M. Á., Xu, Y., Martínez‐González, M. Á., Sayón-Orea, C., Ruiz‐Canela, M., Toledo, E., Martín, V., Estruch, R., et al. (2020) · Molecules · doi:10.3390/molecules25184340 · Cited by 10
Grymyr, L. M. D., Nadirpour, S., Gerdts, E., Nedrebø, B. G., Hjertaas, J. J., Matre, K., & Cramariuc, D. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.10.009 · Cited by 10
Pietrantonio, N. D., Palmerini, C., Pipino, C., BALDASSARRE, M. P. A., Bologna, G., Mohn, A., Giannini, C., Lanuti, P., Chiarelli, F., Pandolfi, A., et al. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166076 · Cited by 10
Aguiar, A., de Queiroz, J. L. C., Santos, P. P. D. A., Camillo, C. D. S., Serquiz, A. C., Costa, I. D. S., de Oliveira, G. S., Gomes, A. F. T., Matias, L. L. R., Costa, R. O., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189968 · Cited by 10
An inverse association between calcium and adiposity in women with high fat and calcium intakes.
Kruger, H. S., Rautenbach, P. H., Venter, C. S., Wright, H. H., & Schwarz, P. E. H. (2007) · PubMed · Cited by 10
Stojanovic, N. D., Lewandowski, K. C., Salata, I., et al. (2010) · Gynecological Endocrinology · doi:10.3109/09513590902972026 · Cited by 10
Maternal serum omentin-1 profile is similar in humans and in the rat animal model
Garcés, M. F., Ruíz-Linares, C. E., Vallejo, S. A., Franco, J. J. P., Sánchez, E., Ortiz-Rovira, A., Curtidor, Y., Parra, M. O., Leal, L. G., Álzate, J. P., et al. (2015) · Cytokine · doi:10.1016/j.cyto.2015.06.014 · Cited by 10
Glucose tolerance in rural diabetic Thais, first-degree relatives and non-diabetic controls
Davis, T. M. E., Pramukkul, P., Suputtamongkol, Y., Chaowagul, W., & Lévy, J. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01039-g · Cited by 10
Li, H., Lee, W., Chen, M.-J., & Chuang, L. (2005) · Obesity Research · doi:10.1038/oby.2005.98 · Cited by 10
Singal, P., Muniyappa, R., Chisholm, R., Hall, G., Chen, H., Quon, M. J., & Mather, K. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00603.2009 · Cited by 10
Hino, A., Inoue, A., Mafune, K., Nakagawa, T., Hayashi, T., & Hiro, H. (2016) · Journal of Occupational Health · doi:10.1539/joh.16-0061-oa · Cited by 10
Evers, S. S., Boersma, G. J., Tamashiro, K. L., Scheurink, A. J. W., & van Dijk, G. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117724749 · Cited by 10
Veissi, M., Jafarirad, S., Ahangarpour, A., Mohaghegh, S. M., & Malehi, A. S. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0009 · Cited by 10
Villalobos-Labra, R., Westermeier, F., Pizarro, C., Sáez, P. J., Toledo, F., Pardo, F., Kusanovic, J. P., Mardones, F., Poblete, J. A., Sobrevía, L., et al. (2019) · Placenta · doi:10.1016/j.placenta.2019.07.007 · Cited by 10
Park, S. H., Lee, W., Lee, Y. S., Rhee, E., & Kim, S. W. (2004) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2004.19.2.75 · Cited by 10
the CALDIA Study Group, Defay, R., Jaussent, I., Lacroux, A., & Fontbonne, A. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803384 · Cited by 10
Novak, E. J., Örtqvist, E., Nord, E., Edwall, L., Hampe, C. S., Bekris, L. M., Persson, B. E., & Lernmark, Å. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.1019 · Cited by 10
Mediano, M. F. F., Barbosa, J. S. D. O., Sichieri, R., & Pereira, R. A. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000600015 · Cited by 10
Aggravation of albuminuria by metabolic syndrome in type 2 diabetic Asian subjects
Lee, I., Huang, C., Lee, W., Lee, H., & Sheu, W. H. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.05.010 · Cited by 11
Pouteau, E. B., Ferchaud‐Roucher, V., Zaïr, Y., Paintin, M., Enslen, M., Auriou, N., Macé, K., Godin, J., Ballèvre, O. P., & Krempf, M. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.05.006 · Cited by 10
Heald, A. H., Anderson, S. G., Vyas, A., Siddals, K. W., Patel, J. V., Yates, A. P., Bhatnagar, D., Prabhakaran, D., Hughes, E. A., Rudenski, A. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1871-7 · Cited by 10
Self-citationIncreased chromium excretion in pregnancy is associated with insulin resistance
Morris, B. W., Samaniego, S., Fraser, R., et al. (2000) · The Journal of Trace Elements in Experimental Medicine · doi:10.1002/1520-670x(2000)13:4 · Cited by 10
Relation between sodium–lithium countertransport and hypertriglyceridemia in type V hyperlipidemia
Wierzbicki, A. S. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01228-0 · Cited by 10
Lipid transfer protein activities in subjects with impaired glucose tolerance
Julius, U., Jauhiainen, M., Ehnholm, C., & Pietzsch, J. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.032 · Cited by 10
Candela, J. M., Nadal, J. F., Ortiz, J. R., Domínguez, C. C., Martín, A. G., & Yepes, M. L. L. (2007) · Medicina Clínica · doi:10.1157/13111806 · Cited by 10
Valsamakis, G., Jones, A. F., Chetty, R., et al. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802185757 · Cited by 10
Markers of endothelial dysfunction in hyperglycaemic Asian Indian subjects
Viswanathan, V., Snehalatha, C., Nair, M. B., & Ramachandran, A. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(03)00037-0 · Cited by 10
Tzotzas, T., Samara, M., Constantinidis, T. C., Τζιόμαλος, Κ., & Krassas, G. E. (2007) · Angiology · doi:10.1177/0003319706297915 · Cited by 10
Bongiovanni, M., Ranieri, R., Casana, M., Tordato, F., Cicconi, P., Tincati, C., Bini, T., & Monforte, A. D. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318158befd · Cited by 10
Wang, B., Yang, G., Yang, M., Liao, Y., Li, Z., Boden, G. H., & Li, L. (2011) · Cytokine · doi:10.1016/j.cyto.2011.11.002 · Cited by 10
Thomas, G. N., Tomlinson, B., Hong, A. W. L., & Hui, S. S. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.581 · Cited by 11
Boronat, M., Saavedra, P., Varillas, V. F., Wägner, A. M., López-Plasencia, Y., Alberiche, M., & Novoa, F. J. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.07.010 · Cited by 10
Karadeniz, M., Erdoğan, M., Berdelı, A., Tamsel, S., Saygılı, F., & Yılmaz, C. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-29 · Cited by 10
Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension
Tamasawa, N., Matsui, J., Ogawa, Y., et al. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00071-4 · Cited by 10
Lack of Association of Glutamate Decarboxylase 2 Gene Polymorphisms with Severe Obesity in Utah
Hunt, S. C., Xin, Y., Wu, L. L., et al. (2006) · Obesity · doi:10.1038/oby.2006.73 · Cited by 10
Clifford, R. M., Davis, W., Cull, C. A., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510579 · Cited by 10
Metabolic characteristics in individuals with impaired glucose homeostasis
Hsieh, C.-H., Kuo, S.-W., Hung, Y.-J., Shen, D.-C., Ho, C.-T., Lian, W.-C., Lee, C., Fan, S. C., & Pei, D. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00494.x · Cited by 10
Role of diabetes in influencing leptin concentration in elderly overweight patients
Passaro, A., Calzoni, F., Zamboni, P., Manservigi, D., Alberti, L., Nora, E. D., Fellin, R., & Solini, A. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450173 · Cited by 10
Further Studies of the Influence of Apolipoprotein B Alleles on Glucose and Lipid Metabolism
Bentzen, J. G., Poulsen, P., Vaag, A. A., et al. (2003) · Human Biology · doi:10.1353/hub.2003.0070 · Cited by 10
Siirtola, A., Antikainen, M., Ala‐Houhala, M., et al. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(03)00201-8 · Cited by 10
Hilczer, M., Smyczyńska, J., Stawerska, R., & Lewiñski, A. (2008) · PubMed · Cited by 10
Osei, K., Gaillard, T. R., Cook, C. A., Kaplow, J. M., Bullock, M., & Schuster, D. (2005) · PubMed · Cited by 10
Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo
Ooi, E. M. M., Watts, G. F., Ji, J., Rye, K., Johnson, A. G., Chan, D. C., & Barrett, P. H. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02662.x · Cited by 11
Bentzen, J., Poulsen, P., Vaag, A. A., Beck-Nielsen, H., & Fenger, M. (2002) · Diabetic Medicine · doi:10.1046/j.0742-3071.2001.00602.x · Cited by 10
QUANTITATIVE MODELLING OF ENDOCRINE DISEASES AS EXEMPLIFIED BY DIABETES
Turner, R. C., Rudenski, A. S., Holman, R. R., Matthews, D. R., & O’Rahilly, S. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb03644.x · Cited by 10
Self-citationApplication of Modelling Techniques to the Assessment of Insulin Sensitivity in Man
Ng, L. L. (1988) · Diabetic Medicine · doi:10.1111/j.1464-5491.1988.tb00973.x · Cited by 10
Iwamoto, K., Mori, H., Okazawa, H., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0871-0 · Cited by 10
Ginis, K. A. M., van der Scheer, J. W., Todd, K. R., et al. (2020) · Spinal Cord · doi:10.1038/s41393-020-0519-2 · Cited by 10
Barbosa, M. A., de Sousa, G. G., de Castro, U. G. M., Carneiro, C. M., Figueiredo, V. P., Guerra de Sá, R., Santos, R. A. S. D., & Alzamora, A. C. (2019) · Nutrition · doi:10.1016/j.nutx.2019.100004 · Cited by 9
Gupta, J., Antal, Z., Mauer, E., Gerber, L. M., An, A., & Censani, M. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01098-0 · Cited by 9
“The homeostasis model assessment (HOMA-IR) and wholebody insulin sensitivity index (WBISI) calculations were performed to assess insulin resistance [19, 20].”
Methodde Luis, D. A., Izaola, O., Primo, D., & Gómez, J. J. L. (2023) · Nutrition · doi:10.1016/j.nut.2023.112170 · Cited by 9
Baumgartner, M., Lischka, J., Schanzer, A., de Gier, C., Walleczek, N.-K., Greber-Platzer, S., & Zeyda, M. (2022) · Nutrients · doi:10.3390/nu14102133 · Cited by 9
Hamrahian, M., Mollaee, M., Anand, M., et al. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.09.036 · Cited by 9
Izaola, O., Primo, D., Hoyos, E. G., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.04.030 · Cited by 9
Gold, R. S., Unkart, J. T., Larsen, B. A., Price, C. A., Cless, M., Araneta, M., & Allison, M. (2021) · Diabetes/Metabolism Research Reviews · doi:10.1002/dmrr.3488 · Cited by 6
Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research
Rani, N., Kumar, P., Mishra, A. K., et al. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_391_21 · Cited by 9
Sun, Y., Zhong, C., Zhou, Z., Lei, Z., & Langrish, T. A. G. (2022) · Processes · doi:10.3390/pr10040759 · Cited by 11
Vitamin D and chronotype: is there any relationship in individuals with obesity?
Vetrani, C., Barrea, L., Verde, L., Docimo, A., Aprano, S., Savastano, S., Colao, A., & Muscogiuri, G. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01973-6 · Cited by 11
Zhou, L., Song, K., & Luo, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1071922 · Cited by 9
Higashioka, M., Hirakawa, Y., Hata, J., Honda, T., Sakata, S., Shibata, M., Kitazono, T., Osawa, H., & Ninomiya, T. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad011 · Cited by 9
Wani, K., Khattak, M. N. K., Saadawy, G. M., Al-Attas, O. S., Alokail, M. S., & Al‐Daghri, N. M. (2023) · Diagnostics · doi:10.3390/diagnostics13020324 · Cited by 10
Zhu, C., Tang, S., Xiao, J., Zhang, Y., Sun, L., Zhang, J., Ding, L., & Liu, M. (2023) · Obesity Facts · doi:10.1159/000528789 · Cited by 9
Skytthe, M. K., Pedersen, F. B., Wernberg, C. W., Chandran, V. I., Krag, A. A., Caterino, T. D., Mandacaru, S. C., Blagoev, B., Lauridsen, M. M., Detlefsen, S., et al. (2023) · Gastro Hep Advances · doi:10.1016/j.gastha.2023.03.006 · Cited by 9
Association of Long-term Antiseizure Medication Use and Incident Type 2 Diabetes Mellitus
Tseng, W.-E. J., Chang, C., Hwang, J., Ko, P., Liu, C., & Lim, S. (2023) · Neurology · doi:10.1212/wnl.0000000000207222 · Cited by 10
Tsilingiris, D., Schimpfle, L., von Rauchhaupt, E., Sulaj, A., Seebauer, L., Bartl, H., Herzig, S., Szendroedi, J., Kopf, S., & Κender, Ζ. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad248 · Cited by 10
Lee, J. S., Sohn, M., Kim, K., Yoon, Y., & Lim, S. K. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0205 · Cited by 11
Rangel‐Baltazar, E., Rodríguez‐Ramírez, S., Cuevas‐Nasú, L., Shamah‐Levy, T., Méndez‐Gómez‐Humarán, I., & Rivera, J. Á. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.06.004 · Cited by 9
Pigsborg, K., Stentoft-Larsen, V., Demharter, S., Aldubayan, M. A., Trimigno, A., Khakimov, B., Engelsen, S. B., Astrup, A. V., Hjorth, M. F., Dragsted, L. O., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1191944 · Cited by 10
Wu, P., Wu, L., Wang, Y., Ye, Y., Yang, X., Yuan, J., Xu, J., Wang, Y., Song, X., Yan, S., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3717 · Cited by 9
Faiz, H., Heiston, E. M., & Malin, S. K. (2023) · Journal of Diabetes Research · doi:10.1155/2023/4618215 · Cited by 8
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
